Biopharmaceuticals

Airlines
Biopharmaceuticals
Biotech
Bitcoin
Daily Rundown
Electric Vehicles
Pharmaceuticals
Stock Picks

Airline Stocks Surge As TSA Sees Weekend Screenings Rise To Highest Level In A Year

Plus, more countries are suspending the use of AstraZeneca’s COVID-19 vaccine on blood clot concerns, Elon Musk has a new title at Tesla, and bitcoin rallied above $61,000 over the weekend.

Read More
Biopharmaceuticals
Daily Rundown
Economy
Electric Vehicles
Pharmaceuticals
Retailers
Specialty Retailers
Stock Picks
Streaming Media
Telecommunication
US Economy

Lordstown Motors Shares Sink After Activist Firm Accuses The EV Maker Of Misleading Investors

Plus, the $1.9 trillion stimulus plan has been signed into law, L Brands shares are up after the Victoria’s Secret owner lifted forecasts and reinstated its dividend, and AT&T said it now expects to see HBO Max and HBO subscribers of up to 150 million by 2025.

Read More
Biopharmaceuticals
Daily Rundown
Economic Trends
Economy
Pharmaceuticals
Retailers
Specialty Retailers
Stock Picks
Telecommunication
US Economy

Jobless Claims Rose Less Than Expected As President Biden Prepares To Sign $1.9 Trillion Stimulus Deal

Plus, AstraZeneca shares are down after Denmark temporarily suspended use of its COVID-19 vaccine, Johnson & Johnson’s coronavirus vaccine was approved for use in the EU, and a group fo activist investors reduced the number of board seats it wants on Kohl’s board.

Read More
Amazon
Auto Industry
Biopharmaceuticals
Biotech
Daily Rundown
Economic Trends
Economy
Electric Vehicles
Gambling
Payment Processors
Stock Picks
Streaming Media
US Economy

Senate Pushes Vote On $1.9 Trillion Stimulus Bill To This Weekend

Plus, jobless claims rose less than expected, Square is taking a stake in Tidal, Amazon is reportedly seeking exclusive streaming rights for the NFL’s Thursday games, and GM and LG Chem are considering building another battery plant in the U.S.

Read More
Biopharmaceuticals
Biotech
Dividends
Fibonacci Retracement
Fundamental Analysis
Health
HeathCare
Pharmaceuticals
Technical Analysis
Value Investing
Value Stocks

GILD is down -8% from an early February peak – is it a buying opportunity, or a warning sign?

Ever since coronavirus found its way to American shores, a lot of media attention has been given to the Healthcare sector – and especially to the Biotechnology industry, where many of the biggest names across the world have been working hard to develop effective treatments for the disease. From the market’s bearish low in mid-March, […]

Read More
Biopharmaceuticals
One Hot Stock

Aclaris Therapeutics, Inc. (ACRS) – Buy Price: $25.50 or better

Buy Price: $25.50 or better Sell Price: TradersPro Sell Signal Aclaris Therapeutics, Inc., a biopharmaceutical company, focuses on developing drug candidates for immuno-inflammatory diseases in the United States. It operates in two segments, Therapeutics and Contract Research. The company offers ESKATA, a formulation of high-concentration hydrogen peroxide topical solution for raised seborrheic keratosis, a common […]

Read More
Biopharmaceuticals
Biotech
Daily Rundown
Earnings Reports
Grocery
Pharmaceuticals
Retailers
Specialty Retailers
Stock Picks

Biden Set To Announce Merck Will Help Produce J&J’s COVID-19 Vaccine

Plus, Target and Kohl’s both delivered earnings beats, Taco Bell-owner Yum Brands bought an A.I. business to help it improve its marketing, and Instacart’s valuation has doubled.

Read More
Airlines
Banking Sector
Biopharmaceuticals
Bitcoin
Daily Rundown
Financial Sector
Fintech
Investment Banks
Manufacturing
Pharmaceuticals
Retailers
Stock Picks

Walmart Just Poached Two Goldman Bankers As The Retailer Ventures Into Consumer Banking

Plus, bitcoin is up after Citi said the digital coin could one day “become the currency of choice for international trade,” Boeing is up after United Airlines said it is buying 25 more 737 Max planes, and another space start-up is going public through a SPAC merger.

Read More
Biopharmaceuticals
Biotech
Cryptocurrency
Daily Rundown
e-commerce
Earnings Reports
Economy
Food Products
Freelance Gig Economy
Retailers
Small Cap
Specialty Retailers
Stock Picks
US Economy

Meme Stocks Are Back As GameStop Surges 85% Higher

Plus, jobless claims fell sharply last week amid harsh winter storms across the central U.S., an analyst says Moderna could soon see a $100 billion valuation, Wayfair reported an earnings miss, and Coinbase is going public.

Read More
Biopharmaceuticals
Daily Rundown
Earnings Reports
Economy
Electric Vehicles
Pharmaceuticals
Retailers
Specialty Retailers
Stock Picks
US Economy

FDA Staff Recommend Johnson & Johnson’s Single-Shot COVID Vaccine For Emergency Use Authorization

Plus, House Democrats are planning to pass the $1.9 trillion coronavirus relief bill on Friday, Lowe’s delivered an earnings beat, and Workhorse shares are down after getting passed over for a contract with the USPS.

Read More
Biopharmaceuticals
Biotech
Dividends
Fibonacci Retracement
Fundamental Analysis
Health
HeathCare
Medical
Pharmaceuticals
Technical Analysis
Value Investing
Value Stocks

Negative Net Income is a fundamental red flag for BMY – but it’s still a good long-term value

There is a lot of fundamental data that I rely on to help paint an overall picture about underlying strength of any stock I might consider using for a value-based investment. While some fundamental investors prefer to work with easy-to-reference, quick-glance data like earnings per share, I prefer to expand my view of a company’s […]

Read More
Biopharmaceuticals
Bitcoin
Daily Rundown
Earnings Reports
Economy
Electric Vehicles
Freelance Gig Economy
Mining
Stock Picks
Tech Stocks
US Economy

Bitcoin Is Now Worth More Than $1 Trillion

Plus, Pfizer is seeking permission to store its COVID-19 vaccine at higher temperatures, Uber lost a key case in the U.K., and Tesla lowered its prices on two vehicles.

Read More
Biopharmaceuticals
Biotech
Defensive Stocks
Dividends
Fibonacci Retracement
Fundamental Analysis
Immunology
Pharmaceuticals
Technical Analysis
Vaccines
Value Investing
Value Stocks

PFE is down -20% in the last two months – is it a bargain?

It has been interesting to see how market commentary seems to have shifted as much as possible away from COVID-related news since the beginning of the year. In one sense, I think that could be a good thing, since there are a lot of issues, economic, political, and otherwise that are worthy of attention. This […]

Read More

Get Top Momentum Stocks with TradersPro

X